Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Editing
Thyroid nodules
(section)
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== '''Cytopathological risk stratification''' == * FNA is preferred technique - gives good enough answer to render larger biopsies such as CNB obsolete, unless lymphoma is a high possibility ** Can technically be done blind, but USS-guided is obviously better ** Mean sensitivity >80%, mean specificity >90% ** 23-27-gauge needle ** Confirm adequacy of specimen at time of biopsy (6 groups of well-visualised follicular cells, 10 cells per group) * Contraindications to FNA: ** Prohibitive surgical risk ** Already proceeding with thyroidectomy ** Extreme elderly with small nodules * Use BETHESDA system for thyroid cytopathology (last updated 2017; below) ** Categories 2 and 6 are highly accurate, with error rate <3% ** Others quite variable - see ranges of malignancy below ** Traditional recommendation for 3 and 4 lesions to have lobectomy, but efforts now to reduce that rate, since most are benign. Molecular testing may help. * Molecular testing ** Complex field. Tests can be considered as either 'rule-in' or 'rule-out' tests. ** Most useful for Bethesda 3 and 4 nodules ** Take into account the holistic picture and order appropriately. ** Afirma Gene Expression Classifier - mostly rule-out - 90% sensitivity, but specificity 50% for Bethesda 3 and 4 nodules ** Afirma Genomic Sequence Classifier - se 91% sp 68%. Particularly poor performance for Hurthle cell adenoma and carcinoma. ** ThyroSeq v2 - se >90% sp >90% in early studies, but subsequent validation outcomes were poor. ** ThyroSeq v3 - se 94% sp 82% in Bethesda 3 + 4, and better performance in Hurthle cell. Costs about $2,100 per nodule in Australia, with no medicare rebate, and takes a couple of weeks. {| class="wikitable" |'''Bethesda class''' |'''Diagnostic category''' |'''Cancer risk''' |- |I |Nondiagnostic (unsatisfactory) |5 to 10% |- |II |Benign |0 to 3% |- |III |Atypia of undetermined significance (AUS) or follicular lesion of undetermined significance (FLUS) |10 to 30% |- |IV |Follicular neoplasm (or suspicious for follicular neoplasm, also encompassing Hurthle cell neoplasm) |25 to 40% |- |V |Suspicious for malignancy |50 to 75% |- |VI |Malignant |97 to 99% |} # Repeat FNA, then excisional biopsy if still indeterminate ## Some surgeons say 2x FNA then 1x core biopsy then consider excision # Repeat follow-up 2-3 years is probably standard for these nodules # Cancer risk is overstated for this group. Consider clinical and radiographical factors (as in, were you expecting a higher Bethesda score based on the TI-RADS?). Consider repeat FNAB or lobectomy. # Typically excised. Mostly found to be follicular adenomas or adenomatoid nodules of MNG. Can't tell the difference between benign and malignant follicular lesions on FNA - need to see whether there is capsular invasion. # Surgical resection # Surgical resection, unless widely metastatic.
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Thyroid nodules
(section)
Add topic